Background: Perioperative bleeding is a predictor of morbidity following liver resection. The
Introduction
Despite improvements in surgical and anaesthetic techniques, postoperative morbidity following liver resection remains high. [1] [2] [3] [4] [5] Perioperative bleeding is one of the major predictors of morbidity [4] [5] [6] and blood transfusion is required in 10-38% of patients undergoing liver resection. 7, 8 Preoperative assessment of the risk for transfusion is useful for enhancing the information given to patients and in the development of a perioperative strategy to minimize the risk. [8] [9] [10] [11] The transfusion-related score (TRS) was proposed by Pulitanò et al. to predict the likelihood of transfusion in liver resection. 8 The score was found to have good overall accuracy, but was developed in a retrospective and monocentre study. The present authors hypothesized that the TRS might be used to accurately predict units of red blood cell (RBC) transfusion at the study liver surgery centre. The purpose of this study was to evaluate the external validity of the TRS in a different population of patients undergoing liver resection.
Materials and methods
According to French legislation for the regulation of clinical research, requirements for the provision of informed consent were waived because the present study was retrospective and observational.
Patients
A retrospective, monocentre, observational cohort study in consecutive patients submitted to elective liver resection during 2008 and 2009 was performed. Standard anaesthesia monitoring was applied perioperatively. A radial arterial catheter and venous central catheter were placed for major hepatectomy. 12 Anaesthesia was induced and maintained at the discretion of the attending anaesthesiologist. Haemoglobin blood levels were repeatedly estimated using a HemoCue Hb 201+ (HemoCue France, Meaux, France). Transfusion criteria followed the American Society of Anesthesiologists (ASA) Task Force and Agence Française de Sécurité Sanitaire recommendations 13,14 for 7-10 g/dl according to cardiovascular status. A haemodynamic strategy with fluid restriction during hepatic resection was applied.
All elective liver surgeries were performed by any of five senior hepatobiliary surgeons. Major liver resection was defined as the resection of three or more hepatic segments. Liver parenchymal transection was conducted using an ultrasonic dissector (Dissectron®; Laboratoire Integra Neurosciences, Saint Priest, France), the Kelliclasie technique or bipolar coagulation. Intermittent pedicular clamping was performed using a protocol of 15 min of clamping followed by 5 min of non-clamping. 15 Inferior vena cava clamping was performed when necessary. The hanging manoeuvre was used to facilitate the anterior approach in major liver resections. [16] [17] [18] Transfusion-related score The TRS is derived from five variables: cirrhosis; preoperative haemoglobin level of ≤12.5 g/dl; tumour size of >4 cm; need for inferior vena cava exposure, and associated extraliver surgical procedure. Each variable can be assigned 1 point and the sum of these points establishes the TRS. 8 
Data collection
The following data were collected from medical records: demographic data, including patient age, sex, body mass index, ASA score, malignant or benign nature of the tumour, and presence of cirrhosis, cardiopulmonary disease and diabetes; surgical data, including the number of resected segments, tumour size, perioperative vena cava exposure, any associated surgical procedure (bilioenteral anastomosis, associated colorectal, pancreatic or renal resections) and duration of surgery; preoperative haemoglobin blood levels, and the number of units of RBC transfused intraoperatively and until postoperative day 5.
Statistical analysis
Data for transfused and non-transfused patients were compared by univariate analysis using Fisher's exact test or the MannWhitney test as appropriate. The plasma haemoglobin level associated with risk for transfusion was investigated using the MannWhitney test with different cut-off values. The frequency of transfusion at each score level was calculated. The accuracy of the TRS was evaluated using the area under the receiver operator characteristic (ROC) curve (AUC).
Data are presented as the median [interquartile range (IQR)] or number (percentage). All analyses were two-tailed; a P-value of <0.05 was accepted as indicating statistical significance. Statistical analysis was performed using stata Version 9.2 (StataCorp LP, College Station, TX, USA).
Results
A total of 205 consecutive patients submitted to scheduled liver surgery during the study period were included. Forty-eight (23.4%) patients were transfused; they received a median of 2 units (IQR: 2-4 units) of RBC. Demographic and surgical data for transfused and non-transfused patients are displayed in Table 1 . There were no significant differences between transfused and non-transfused patients in age, ASA score or presence of cirrhosis. The distribution of RBC units among the 48 transfused patients is detailed in Fig. 1 .
Among the items contributing to the TRS, a preoperative haemoglobin level cut-off of 12.5 g/dl, tumour size and cirrhosis were not significantly associated with transfusion in univariate analysis, whereas inferior vena cava exposure and associated surgical procedures were significantly associated with risk for transfusion (P = 0.012 and P = 0.029, respectively). Univariate analysis showed a preoperative haemoglobin level of <12.3 g/dl to be associated with transfusion (P = 0.008). Transfusion rates for each TRS level are reported in Table 2 and Fig. 2 . For the 163 patients (of the total population of 205 patients) for which the TRS was available. The ROC AUC for the original TRS was 0.68 [95% confidence interval (CI) 0.59-0.77] (Fig. 3) .
Using a preoperative haemoglobin cut-off value of 12.3 g/dl as one item in the score led to an AUC of 0.69 (95% CI 0.58-0.76).
Discussion
The current study was designed to evaluate the external validity of the TRS in predicting perioperative transfusion during liver resection. Of the original TRS items, only intraoperative inferior vena cava exposure and associated surgical procedure were significantly associated with perioperative RBC transfusion in the present study population. The discriminating power of the TRS in this population was moderate and does not allow for the reliable prediction of RBC transfusion.
Preoperative haemoglobin level is a consistent predictor of transfusion, regardless of the type of surgery, but the thresholds cited vary among studies. 8, 10, 11, [19] [20] [21] [22] For example, in liver surgery, Itamoto et al. found preoperative haemoglobin level at a threshold value of 11 g/dl to be the only predictor of intraoperative transfusion, 20 whereas Cockbain et al. identified a threshold value of 12.5 g/dl. 10 In the present population, risk for transfusion was not significantly associated with a preoperative haemoglobin level of <12.5 g/dl, but was significantly associated with a preoperative haemoglobin level of <12.3 g/dl. This may reflect variability in transfusion practices. However, even with a threshold of 12.3 g/dl, the ROC AUC for the TRS remained moderate.
Cirrhosis is a well-known risk factor for transfusion during liver surgery. 9, 23, 24 However, patients with cirrhosis in the present study displayed only a non-significant trend towards increased 
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HPB 2015, 17, 357-361 need for transfusion. This result may be related to the fact that the number of patients with cirrhosis in the present study was relatively low, which may imply insufficient power to detect this small difference. An additional explanation may refer to the severity of cirrhosis in resected patients. In accordance with current practices, elective liver surgery was performed in highly selected patients with cirrhosis (i.e. those with Child-Pugh class A status or very selected patients of Child-Pugh class B status) to limit the risk for haemorrhage related to portal hypertension or coagulation disorders. 19, 20 Tumour size has been proposed as an item contributing to the TRS because of tumour rich vascularization and parenchymal congestion. 8, 10 However, this item was not significantly associated with transfusion in the present study. This discrepancy may refer to the fact that the difficulty of the surgery seems to relate to tumour localization more than it does to tumour size. 9 Moreover, improvements in surgical and perioperative management may also explain this result. In the current study, among the original TRS items, inferior vena cava exposure and concomitant extrahepatic procedures were the only surgical factors to be consistently confirmed, as significantly associated with need for RBC transfusion in liver surgery.
Finally, the varied case mix, different surgical techniques and skills used and varied transfusion practices, in combination, are likely to have impacted on the present results. All of these factors are subject to significant variability among surgical teams and thus it can be hypothesized that a universally reliable predictive score is likely to be very difficult to establish.
The present study is subject to some limitations that must be acknowledged. This was a retrospective study and lacks data justifying the delivery of transfusion for each patient (perioperative blood loss and haemoglobin value at the time of transfusion). Moreover, the present study population (n = 205) was smaller than that in the study by Pulitanò et al. 8 (n = 320), and the frequency of cirrhosis was lower [15 patients (7.3%) versus 82 (25.6%) patients]. Nevertheless, before any prognostic model can be extended to other populations, external validation is necessary 25 and should ideally be performed in a population other than that of the initial research.
In conclusion, in the present population of patients undergoing liver resection, the TRS appeared to be a weak predictor of perioperative transfusion, although each of the contributing items seemed clinically relevant. This study confirms that the external validity of a score for predicting need for transfusion should be subjected to further investigation before it can be implemented in a clinical setting. 
